Skip to main content
Diamines & Chemicals Ltd. logo

Diamines & Chemicals Ltd. — Investor Relations & Filings

Ticker · DIAMINESQ ISIN · INE591D01014 LEI · 335800AQNIZET87LXI95 BSE.NS Manufacturing
Open in API
Filings indexed 873 across all filing types
Latest filing 2023-08-05 Regulatory Filings
Country IN India
Listing BSE.NS DIAMINESQ

About Diamines & Chemicals Ltd.

https://dacl.co.in/

Diamines & Chemicals Ltd. specializes in the production of ethylene amines and related chemical intermediates. The company’s core product portfolio includes Ethylenediamine (EDA), Diethylenetriamine (DETA), Triethylenetetramine (TETA), Tetraethylenepentamine (TEPA), and Piperazine. These specialty chemicals are utilized across diverse sectors, including pharmaceuticals, agrochemicals, polyamide resins, and water treatment. The firm operates integrated manufacturing facilities designed for the synthesis of high-purity organic compounds. By leveraging advanced chemical processes, it provides essential raw materials for applications in oilfield chemicals, textile auxiliaries, and paper chemicals. The organization maintains a focus on technical excellence and process innovation to meet the stringent requirements of global supply chains.

Recent filings

Filing Released Lang Actions
We submit herewith information regarding letter of confirmation received from Registrar and Share Transfer Agent of the Company.
Regulatory Filings Classification · 95% confidence The document is an intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the issuance of duplicate share certificates to shareholders. It lists shareholder names, folio numbers, certificate numbers, and share details. This is a regulatory announcement related to share certificates and compliance with SEBI regulations, not a financial report, management change, or voting result. The document is relatively short (2385 characters) and serves as a formal notification to the stock exchange. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-08-05 English
We submit herewith Unaudited Financial Results for the quarter ended June 30, 2023
Interim / Quarterly Report Classification · 100% confidence The document is a detailed announcement from the Board of Directors of Diamines and Chemicals Limited dated August 4, 2023. It includes the approval of unaudited standalone and consolidated financial results for the quarter ended June 30, 2023, along with a limited review report by independent auditors. The document contains actual financial data such as revenue, expenses, profit before tax, tax expenses, and earnings per share for the quarter. It also discusses board decisions like reappointment of a director and capital investment approvals. The presence of comprehensive financial statements and auditor's review indicates this is an Interim / Quarterly Report rather than just an announcement or certification. The document length (15,000 characters) and detailed financial data confirm it is not a brief announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR). Q1 2024
2023-08-04 English
Outcome of Board Meeting held on August 04, 2023
Interim / Quarterly Report Classification · 100% confidence The document is dated August 4, 2023, and contains detailed unaudited standalone financial results for the quarter ended June 30, 2023. It includes a limited review report by independent auditors, financial tables with revenue, expenses, profit, and other comprehensive income, as well as segment-wise revenue and results. The document also includes board meeting outcomes related to approval of these financial results and other corporate actions. The presence of detailed financial data and analysis for a quarter, along with auditor's review, clearly identifies this as an Interim / Quarterly Report. It is not merely an announcement or a certification but contains substantive financial information and analysis for the quarter. Therefore, the correct classification is Interim / Quarterly Report (IR).
2023-08-04 English
We herewith submit grant of Stock Options under DACL - ESOP 2021 approved by Nomination and Remuneration Committee at their meeting held on August 03, 2023 to the eligible employee of DACL ....
Capital/Financing Update Classification · 95% confidence The document is a formal announcement addressed to a stock exchange (BSE Limited) regarding the grant of stock options under an Employee Stock Option Plan (ESOP) for a subsidiary company. It references compliance with SEBI Listing Obligations and Disclosure Requirements (SEBI LODR) and provides detailed disclosure as per SEBI regulations. The content focuses on the approval and details of stock options granted, including the number of options, vesting schedule, exercise price, and other terms. There is no financial performance data, earnings information, or management discussion. The document is an update on capital structure related to employee stock options, which fits the category of Capital/Financing Update (CAP). The document length is about 5292 characters, which is sufficient for a detailed announcement rather than a brief notice or a report publication announcement. Therefore, the classification is Capital/Financing Update (CAP).
2023-08-03 English
DIAMINES & CHEMICALS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2023 ,inter alia, to consider and approve Unaudited Financial ....
Regulatory Filings Classification · 95% confidence The document is a short notice informing about a scheduled meeting of the Board of Directors to consider and approve unaudited financial results for the quarter ended June 30, 2023. It references compliance with SEBI (LODR) regulations and is addressed to the stock exchange. The document does not contain any financial data or results itself, nor does it include detailed financial statements or analysis. It is essentially an announcement of an upcoming board meeting where financial results will be approved. Given the short length (1291 characters) and the nature of the content, this fits the category of a Regulatory Filing (RNS) as a general regulatory announcement rather than an Interim/Quarterly Report (IR) or Earnings Release (ER).
2023-07-24 English
We submit information regarding loss/misplaced/non-receipt of share certificates received from Registrar and Share Transfer Agent of the Company.
Regulatory Filings Classification · 95% confidence The document is an intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the loss/misplacement/non-receipt of share certificates and the issuance of duplicate share certificates. It is a regulatory announcement related to share certificate status and compliance with listing obligations. The document is short (1981 characters) and serves as a notification rather than a financial report or detailed filing. It does not contain financial data, management discussion, or audit information. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-07-24 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.